Molecular Pharmacology: 46 (4)

October 01, 1994; Volume 46,Issue 4

You have access
Omega-agatoxin-TK containing D-serine at position 46, but not synthetic omega-[L-Ser46]agatoxin-TK, exerts blockade of P-type calcium channels in cerebellar Purkinje neurons.
M Kuwada, T Teramoto, K Y Kumagaye, K Nakajima, T Watanabe, T Kawai, Y Kawakami, T Niidome, K Sawada and Y Nishizawa

Molecular Pharmacology October 1994, 46 (4) 587-593;
You have access
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.
S M De Morais, G R Wilkinson, J Blaisdell, U A Meyer, K Nakamura and J A Goldstein

Molecular Pharmacology October 1994, 46 (4) 594-598;
You have access
Gold sodium thiomalate down-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells.
R Koike, I Miki, M Otoshi, T Totsuka, H Inoue, H Kase, I Saito and N Miyasaka

Molecular Pharmacology October 1994, 46 (4) 599-604;
You have access
Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
M K Ritke, J M Rusnak, J S Lazo, W P Allan, C Dive, S Heer and J C Yalowich

Molecular Pharmacology October 1994, 46 (4) 605-611;
You have access
Induction of aggregation and augmentation of protein kinase-mediated phosphorylation of purified vimentin intermediate filaments by withangulatin A.
M D Perng, T J Cheng, C M Chen and Y K Lai

Molecular Pharmacology October 1994, 46 (4) 612-617;
You have access
Physicochemical and immunocytochemical analysis of the aryl hydrocarbon receptor nuclear translocator: characterization of two monoclonal antibodies to the aryl hydrocarbon receptor nuclear translocator.
N G Hord and G H Perdew

Molecular Pharmacology October 1994, 46 (4) 618-626;
You have access
Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
J S Lee, K Paull, M Alvarez, C Hose, A Monks, M Grever, A T Fojo and S E Bates

Molecular Pharmacology October 1994, 46 (4) 627-638;
You have access
Time course of 72-kilodalton heat shock protein induction and appearance of trifluoroacetyl adducts in livers of halothane-exposed rats.
W Q Lin, R A van Dyke, H M Marsh and J R Trudell

Molecular Pharmacology October 1994, 46 (4) 639-643;
You have access
Kinetics and reversibility of thyrotropin-releasing hormone-stimulated guanine nucleotide exchange in membranes from GH4C1 cells.
K D Brady, B Han and A H Tashjian

Molecular Pharmacology October 1994, 46 (4) 644-652;
You have access
Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression.
G Nickenig and T J Murphy

Molecular Pharmacology October 1994, 46 (4) 653-659;
You have access
L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.
R Bangalore, N Baindur, A Rutledge, D J Triggle and R S Kass

Molecular Pharmacology October 1994, 46 (4) 660-666;
You have access
Cocaine differentially regulates activator protein-1 mRNA levels and DNA-binding complexes in the rat striatum and cerebellum.
P Couceyro, K M Pollock, K Drews and J Douglass

Molecular Pharmacology October 1994, 46 (4) 667-676;
You have access
Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines.
M N Benchekroun, E Schneider, A R Safa, A J Townsend and B K Sinha

Molecular Pharmacology October 1994, 46 (4) 677-684;
You have access
Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.
M Waelbroeck

Molecular Pharmacology October 1994, 46 (4) 685-692;
You have access
Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
S Nouet, P Dodey, P Renaut, J Marie, D Pruneau, R Larguier, C Lombard and J C Bonnafous

Molecular Pharmacology October 1994, 46 (4) 693-701;
You have access
Membrane-permeant derivatives of cyclic AMP optimized for high potency, prolonged activity, or rapid reversibility.
C Schultz, M Vajanaphanich, H G Genieser, B Jastorff, K E Barrett and R Y Tsien

Molecular Pharmacology October 1994, 46 (4) 702-708;
You have access
Biological studies of a nitroso compound that releases nitric oxide upon illumination.
S J Pou, D E Anderson, W Surichamorn, L L Keaton and M L Tod

Molecular Pharmacology October 1994, 46 (4) 709-715;
You have access
Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons.
C C Kuo and B P Bean

Molecular Pharmacology October 1994, 46 (4) 716-725;
You have access
Radiation inactivation studies of the dopamine reuptake transporter protein.
S P Berger, K Farrell, D Conant, E S Kempner and S M Paul

Molecular Pharmacology October 1994, 46 (4) 726-731;
You have access
Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro.
P Morain, C Abraham, B Portevin and G De Nanteuil

Molecular Pharmacology October 1994, 46 (4) 732-742;
You have access
Identical inhibitory modulation of A-type potassium currents by dihydropyridine calcium channel agonists and antagonists.
B Mlinar and J J Enyeart

Molecular Pharmacology October 1994, 46 (4) 743-749;
You have access
Positive regulation by chloride channel blockers of IsK channels expressed in Xenopus oocytes.
A E Busch, T Herzer, C A Wagner, F Schmidt, G Raber, S Waldegger and F Lang

Molecular Pharmacology October 1994, 46 (4) 750-753;
You have access
ATP-sensitive K+ channels of skeletal muscle fibers from young adult and aged rats: possible involvement of thiol-dependent redox mechanisms in the age-related modifications of their biophysical and pharmacological properties.
D Tricarico and D C Camerino

Molecular Pharmacology October 1994, 46 (4) 754-761;
You have access
Effects of bretylium tosylate on voltage-gated potassium channels in human T lymphocytes.
R Gáspár, G Panyi, D L Ypey, Z Krasznai, G Vereb, C Pieri and S Damjanovich

Molecular Pharmacology October 1994, 46 (4) 762-766;
You have access
Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2',3'-dideoxynucleosides.
W Y Gao, D G Johns and H Mitsuya

Molecular Pharmacology October 1994, 46 (4) 767-772;
You have access
Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrine.
J L Nitiss, P M Vilalta, H Wu and J McMahon

Molecular Pharmacology October 1994, 46 (4) 773-777;
You have access
Involvement of phenyl radicals in iodonium inhibition of flavoenzymes.
V B O'Donnell, G C Smith and O T Jones

Molecular Pharmacology October 1994, 46 (4) 778-785;
You have access
Ethanol-derived immunoreactive species formed by free radical mechanisms.
C Moncada, V Torres, G Varghese, E Albano and Y Israel

Molecular Pharmacology October 1994, 46 (4) 786-791;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals